Cancer Health Treatment Update Missing a Routine Mammogram Increases Risk of Breast Cancer Death The findings coincide with plummeting breast cancer screening rates due, in part, to COVID-19 pandemic fears and barriers. Enlarged Lymph Nodes After COVID-19 Vaccine May Be Mistaken for Metastasis The vaccination side effect is harmless and temporary, but for people living with cancer, it can lead to unnecessary tests and worry. FDA Approves Yescarta for Follicular Lymphoma The CAR-T therapy led to complete remission in 60% of people with relapsed or refractory follicular lymphoma. People With HIV and Hepatitis B Need Ongoing Liver Cancer Monitoring People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy. Advertisement Survey Finds COVID-19 Vaccine Hesitancy Among Those With Blood Cancer The reluctance comes despite serious risk of COVID-19 complications for people with blood cancers such as leukemia and lymphoma. Reopening of Long-Term Care Facilities Is ‘an Absolute Necessity for Our Well-Being’ Many residents in long-term care facilities are suffering from depression and loneliness after months without visitors. More News About COVID-19 For more news about the novel coronavirus and COVID-19, including how it affects people living with cancer, visit our sister site, COVID Health.com. Cancer Health Winter 2021 Check out our latest print edition! Newsfeed Missing One Routine Mammogram Increases Risk of Breast Cancer Death Enlarged Lymph Nodes After COVID-19 Vaccine May Be Mistaken for Cancer Metastasis Survey Finds COVID-19 Vaccine Hesitancy Among Those With Blood Cancer The Pandemic Is Harming Women’s Health Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Libtayo for Basal Cell Carcinoma Newsfeed Missing One Routine Mammogram Increases Risk of Breast Cancer Death Enlarged Lymph Nodes After COVID-19 Vaccine May Be Mistaken for Cancer Metastasis Survey Finds COVID-19 Vaccine Hesitancy Among Those With Blood Cancer The Pandemic Is Harming Women’s Health Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Follicular Lymphoma FDA Approves Lorbrena for Metastatic ALK-Positive Lung Cancer FDA Approved Pepaxto for Heavily Treated Multiple Myeloma FDA Approves Libtayo for Basal Cell Carcinoma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: